These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 14555513

  • 1. Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival.
    Dai DL, Makretsov N, Campos EI, Huang C, Zhou Y, Huntsman D, Martinka M, Li G.
    Clin Cancer Res; 2003 Oct 01; 9(12):4409-14. PubMed ID: 14555513
    [Abstract] [Full Text] [Related]

  • 2. Integrin-linked kinase expression increases with prostate tumor grade.
    Graff JR, Deddens JA, Konicek BW, Colligan BM, Hurst BM, Carter HW, Carter JH.
    Clin Cancer Res; 2001 Jul 01; 7(7):1987-91. PubMed ID: 11448915
    [Abstract] [Full Text] [Related]

  • 3. Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma.
    Ito R, Oue N, Zhu X, Yoshida K, Nakayama H, Yokozaki H, Yasui W.
    Virchows Arch; 2003 Feb 01; 442(2):118-23. PubMed ID: 12596061
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
    Dai DL, Martinka M, Li G.
    J Clin Oncol; 2005 Mar 01; 23(7):1473-82. PubMed ID: 15735123
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
    Wang Y, Dai DL, Martinka M, Li G.
    Clin Cancer Res; 2007 Jul 15; 13(14):4111-6. PubMed ID: 17634537
    [Abstract] [Full Text] [Related]

  • 6. Integrin-linked kinase activity is associated with interleukin-1 alpha-induced progressive behavior of pancreatic cancer and poor patient survival.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    Oncogene; 2006 Jun 01; 25(23):3237-46. PubMed ID: 16407822
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
    Väisänen AH, Kallioinen M, Turpeenniemi-Hujanen T.
    Hum Pathol; 2008 Mar 01; 39(3):377-85. PubMed ID: 18187184
    [Abstract] [Full Text] [Related]

  • 8. Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation.
    Janji B, Melchior C, Vallar L, Kieffer N.
    Oncogene; 2000 Jun 22; 19(27):3069-77. PubMed ID: 10871859
    [Abstract] [Full Text] [Related]

  • 9. Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancer.
    Takanami I.
    BMC Cancer; 2005 Jan 05; 5():1. PubMed ID: 15631637
    [Abstract] [Full Text] [Related]

  • 10. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G, Castello G.
    Clin Cancer Res; 2005 Mar 01; 11(5):1835-41. PubMed ID: 15756007
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A, Nakanishi Y, Yoshimura K, Sasajima Y, Yamazaki N, Yamamoto A, Hanada K, Kanai Y, Hirohashi S.
    Cancer; 2005 Apr 15; 103(8):1693-700. PubMed ID: 15751018
    [Abstract] [Full Text] [Related]

  • 12. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.
    Arch Dermatol; 2009 Oct 15; 145(10):1105-13. PubMed ID: 19841396
    [Abstract] [Full Text] [Related]

  • 13. Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis.
    Shimizu M, Kondo S, Urushihara M, Takamatsu M, Kanemoto K, Nagata M, Kagami S.
    Nephrol Dial Transplant; 2006 Sep 15; 21(9):2380-90. PubMed ID: 16728424
    [Abstract] [Full Text] [Related]

  • 14. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
    Sanki A, Li W, Colman M, Karim RZ, Thompson JF, Scolyer RA.
    Pathology; 2007 Dec 15; 39(6):551-7. PubMed ID: 18027257
    [Abstract] [Full Text] [Related]

  • 15. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A, Melanoma Group of the European Organization for Research and Treatment of Cancer.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):472-82. PubMed ID: 16595783
    [Abstract] [Full Text] [Related]

  • 16. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
    Shi Q, Bao S, Song L, Wu Q, Bigner DD, Hjelmeland AB, Rich JN.
    Oncogene; 2007 Jun 14; 26(28):4084-94. PubMed ID: 17213807
    [Abstract] [Full Text] [Related]

  • 17. Novel role for RGS1 in melanoma progression.
    Rangel J, Nosrati M, Leong SP, Haqq C, Miller JR, Sagebiel RW, Kashani-Sabet M.
    Am J Surg Pathol; 2008 Aug 14; 32(8):1207-12. PubMed ID: 18580492
    [Abstract] [Full Text] [Related]

  • 18. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A.
    BMC Cancer; 2007 Aug 10; 7():156. PubMed ID: 17692120
    [Abstract] [Full Text] [Related]

  • 19. COX-2 expression in malignant melanoma: a novel prognostic marker?
    Becker MR, Siegelin MD, Rompel R, Enk AH, Gaiser T.
    Melanoma Res; 2009 Feb 10; 19(1):8-16. PubMed ID: 19430402
    [Abstract] [Full Text] [Related]

  • 20. JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma.
    Lu J, Tang Y, Farshidpour M, Cheng Y, Zhang G, Jafarnejad SM, Yip A, Martinka M, Dong Z, Zhou J, Xu J, Li G.
    Carcinogenesis; 2013 Dec 10; 34(12):2778-88. PubMed ID: 24064223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.